SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-305617
Filing Date
2020-11-30
Accepted
2020-11-30 16:31:01
Documents
2
Group Members
ABG MANAGEMENT LTD.ABG WTT-MEDAVAIL LTDABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTDABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP, L.P.ALLY BRIDGE GROUP (NY) LLCALLY BRIDGE MEDALPHA MANAGEMENT GP, LLCALLY BRIDGE MEDALPHA MANAGEMENT L.P.ALLY BRIDGE

Document Format Files

Seq Description Document Type Size
1 SC 13D d18014dsc13d.htm SC 13D 188826
2 EX-1 d18014dex1.htm EX-1 14757
  Complete submission text file 0001193125-20-305617.txt   205907
Mailing Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4
Business Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4 973-509-0444
MedAvail Holdings, Inc. (Subject) CIK: 0001402479 (see all company filings)

IRS No.: 900772394 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86120 | Film No.: 201358452
SIC: 2834 Pharmaceutical Preparations

Mailing Address UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG K3 00000
Business Address UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG K3 00000 (852) 3121-9699
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. (Filed by) CIK: 0001808684 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D